Allogenic Stem Cell Therapy Market segment, Global Trends, Share, Industry Size, Growth, Demand by 2030

Data Bridge Market Research analyses that the allogenic stem cell therapy market, which was USD 994.9 million in 2022, is expected to reach USD 2109.50 million by 2030, at a CAGR of 9.85% during the forecast period 2023 to 2030.

"The Global  Allogenic Stem Cell Therapy Market report is the outcome of a meticulous market analysis conducted by a team of industry experts, skilled analysts, dynamic forecasters, and knowledgeable researchers. This comprehensive report provides insights into market status, market share, growth rate, future trends, market drivers, opportunities, challenges, risks, entry barriers, sales channels, and distributors. Serving as an invaluable source, the Allogenic Stem Cell Therapy Market report facilitates unparalleled insights and understanding of optimal market opportunities in relevant sectors. Businesses can leverage this information to make informed decisions regarding their production and marketing strategies.

This extensive analysis considers all major players' company profiles and brands, emphasizing the variation in Compound Annual Growth Rate (CAGR) values for the historic year 2019, the base year 2020, and the forecast year 2021-2028. The market study aids businesses in identifying key opportunities and influential factors, guiding them to reach new heights. The Allogenic Stem Cell Therapy Market business report is a professional and detailed document focusing on primary and secondary drivers, market share, leading segments, and geographical analysis.

Data Bridge Market Research analyses that the allogenic stem cell therapy market, which was USD 994.9 million in 2022, is expected to reach USD 2109.50 million by 2030, at a CAGR of 9.85% during the forecast period 2023 to 2030.

Explore Further Details about This Research Allogenic Stem Cell Therapy Market Report https://www.databridgemarketresearch.com/reports/global-allogenic-stem-cell-therapy-market

Allogenic Stem Cell Therapy Market Scope and Segmentation

REPORT METRIC

DETAILS

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells), Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells, Others), Applications (Musculoskeletal Disorders, Wounds, Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, Other), End Users (Therapeutic Companies, Cell, and Tissues Banks, Tools and Reagent Companies, Service Companies)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Athersys Inc. (U.S.), Mesoblast Ltd (Australia), Biorestorative Therapies Inc. (U.S.), Pluristem Inc. (Israel), Brainstorm Cell Limited. (U.S.), ViaCyte Inc. (U.S.), Gamida Cell (U.S.), HOPE BIOSCIENCES (U.S.), Cellular Biomedicine Group (U.S.), Smith+Nephew (U.K.), MEDIPOST (South Korea), ANTEROGEN.CO, LTD. (South Korea), NuVasive Inc. (U.S.), RTI Surgical (U.S.), AlloSource (U.S.), JCR Pharmaceuticals Co. Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan)

Market Opportunities

  • Potential of stem cells for drug discovery
  • Increased product launches in the global market
 

Market Definition

Stem cell therapy, also known as regenerative medicine, uses stem cells or their derivatives to promote the repair response of dysfunctional,diseased, or injured tissue. Stem cells can develop into various types of cells in the body. Pluripotent and multipotent stem cells are the two main types of stem cells. Pluripotent stem cells are replicating cells that develop from embryonic or fetal tissues. Pluripotent stem cells help the cells and tissues develop in three primary germ layers: mesoderm, ectoderm, and endoderm.

Global Allogenic Stem Cell Therapy Market Dynamics

Drivers

• Increasing funding for stem cell research projects

The need for newer and better therapies for auto-immune, neurobiological, and coronary heart disease treatment has increased cumulative research activities and funding for cell-based research. For instance, the University of Sydney was awarded $6.3 million in June 2021 for three projects addressing adult vision loss and cardiovascular events and improving decisions about access to stem cell interventions. In the same year, Stanford physician-researchers were awarded nearly $31 million by the California Institute for Regenerative Medicine to begin first-in-human trials of stem therapies for treating stroke, heart failure, and a type of brain and spinal cord tumor. These are certain factors that propel the growth of the market.

• Rising number of launches

Increased product launches by key market players are expected to drive the market during the forecast period. For instance, LifeCell, a healthcare service provider, introduced an advanced umbilical cord-stem cell collection kit in August 2017 that protects neonatal stem cells from environmental damage and temperature fluctuations.

Opportunities

• Potential of stem cells for drug discovery

The ability to continuously develop functioning adult tissues in culture using directed differentiation opens up new avenues for drug discovery. Before conducting in vivo trials, researchers can create distinct cell lines and then test novel medications on each cell type in vitro to identify potential interactions. This is critical in developing medicines for use in veterinary research because of the possibility of species-specific combinations. The goal is to having the cell lines available for research use that will reduce the need for research animals because in vitro effects on human tissue will provide insight not previously known before the animal testing phase. These all are the factors which are expected to boost the market growth.

 

Answers That the Report Acknowledges:

  • Market size and growth rate during forecast period
  • Key factors driving the Allogenic Stem Cell Therapy Market
  • Key market trends cracking up the growth of the Allogenic Stem Cell Therapy Market.
  • Challenges to market growth
  • Key vendors of Allogenic Stem Cell Therapy Market
  • Opportunities and threats faces by the existing vendors in Global Allogenic Stem Cell Therapy Market
  • Trending factors influencing the market in the geographical regions
  • Strategic initiatives focusing the leading vendors
  • PEST analysis of the market in the five major regions

Browse Related Reports:

Beauty Devices Market is expected to Reach the Valuation Billion by Size, Share, Growth, Trends, Demand and Opportunity Analysis

https://www.databridgemarketresearch.com/reports/global-beauty-devices-market

Chronic Disease Management Market to Grasp Outstanding Growth of Million by, Size, Share, Trends, Opportunities, Key Drivers and Revenue Forecast

https://www.databridgemarketresearch.com/reports/global-chronic-disease-management-market

Point-of-Care Testing (POCT) Market to Exhibit an Incredible Growth of Billion by Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis

https://www.databridgemarketresearch.com/reports/point-care-testing-poct-market

Menstrual Cramps Treatment Market is Probable to Influence the Value of Billion by Size, Share, Trends, Industry Growth and Competitive Outlook

https://www.databridgemarketresearch.com/reports/global-menstrual-cramps-treatment-market

Autism Therapy Market to Receive Highest Growth of Billion by Size, Shares, Trends, Future Demand, Growth and Revenue Analysis

https://www.databridgemarketresearch.com/reports/global-autism-therapy-market

Pharmaceutical Logistics Market to Grasp Outstanding Growth of Billion by Size, Share, Trends, Opportunities, Key Drivers and Growth Prospectus

https://www.databridgemarketresearch.com/reports/global-pharmaceutical-logistics-market

Cleanroom Technology Market to Observe Prominent CAGR Growth by Size, Share, Trends, Demand, Growth and Competitive Analysis

https://www.databridgemarketresearch.com/reports/global-cleanroom-technology-market

Flow Cytometry Market to Perceive Highest Growth of Billion by Size, Share, Trends, Key Drivers, Growth, Challenges and Opportunity Forecast

https://www.databridgemarketresearch.com/reports/global-flow-cytometry-market

Posture Corrector Market is Probable to Influence the Value of Billion by Size, Share, Trends, Growth, Demand, Challenges and Competitive Analysis

https://www.databridgemarketresearch.com/reports/global-posture-corrector-market

Medical Second Opinion Market to Notice Prominent Growth of Billion by Size, Share, Trends, Demand, Industry Growth and Competitive Outlook

https://www.databridgemarketresearch.com/reports/global-medical-second-opinion-market

Hematopoietic Stem Cell Transplantation Market Is Likely to Upsurge at Billion Globally by Size, Share, Trends, Demand, Growth and Opportunity Analysis

https://www.databridgemarketresearch.com/reports/global-hematopoietic-stem-cell-transplantation-market

About Data Bridge Market Research:

 US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]

"

Mais artigos:

Search